You don't have permission to access "http://www.medpagetoday.com/obgyn/ovariancancer/122548" on this server. Reference #18.e8b13717.1786384951.299149b9 https://errors.edgesuite.net/18.e8b13717.1786384951.299149b9
Get the latest coronavirus numbers, news and helpful infoCORONAVIRUS NEWS | Stay up to date with the latest news, views and analysis BEYOND COVID-19 | Trends, change and recovery With the completion date of the project expected to be in June, Sisulu said it was important to begin the project immediately. "We need to do this as…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f